Cargando…
Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy
In many human cancers, the receptor tyrosine kinase (RTK) Tie2 plays important roles in mediating proliferation, survival, migration and angiogenesis. Thus, molecules that could potently inhibit activation of the Tie2 receptor would have a significant impact on cancer therapy. Nevertheless, attempts...
Autores principales: | Shlamkovich, Tomer, Aharon, Lidan, Barton, William A., Papo, Niv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464891/ https://www.ncbi.nlm.nih.gov/pubmed/28422724 http://dx.doi.org/10.18632/oncotarget.16827 |
Ejemplares similares
-
Targeting the Tie2–α(v)β(3) integrin axis with bi-specific reagents for the inhibition of angiogenesis
por: Shlamkovich, Tomer, et al.
Publicado: (2018) -
Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1 and Fibronectin
por: Dalton, Annamarie C., et al.
Publicado: (2016) -
Correction: Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1 and Fibronectin
por: Dalton, Annamarie C., et al.
Publicado: (2017) -
Engineered ligand‐based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis
por: Kapur, Shiven, et al.
Publicado: (2017) -
Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell
por: Arkadash, Valeria, et al.
Publicado: (2018)